|
Market Closed -
OTC Markets
01:29:25 10/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0250 USD | -3.85% |
|
0.00% | -3.85% |
| 19/05 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 17/11 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Stock exchange
OTC Markets
ADAPY 0.0250 $
-3.85%
5.57T
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ADAPY | 0.0250USD | -3.85% | 5.57T $ |
Quotes 5-day view: Adaptimmune Therapeutics plc
Delayed Quote OTC Markets
| 02/09/2026 | 03/09/2026 | 04/09/2026 | 08/09/2026 | 09/09/2026 | |
|---|---|---|---|---|---|
| Last | $0.0250 | $0.0260 | $0.0268 | $0.0260 | $0.0250 |
| Volume | 62,826 | 82,887 | 92,660 | 68,147 | 2,22,681 |
| Change | -7.41% | +4.00% | +3.08% | -2.99% | -3.85% |
| Opening | $0.0205 | $0.0202 | $0.0220 | $0.0210 | $0.0260 |
| High | $0.0270 | $0.0270 | $0.0268 | $0.0268 | $0.0260 |
| Low | $0.0205 | $0.005000 | $0.0210 | $0.0200 | $0.0210 |
Performance
| 1 day | -3.85% | ||
| Current month | +11.11% | ||
| 1 month | -16.67% | ||
| 3 months | -24.01% | ||
| 6 months | +150.00% | ||
| Current year | -3.85% | ||
| 1 year | -49.19% | ||
| 3 years | -96.60% | ||
| 5 years | -99.60% | ||
| 10 years | -99.66% |
Volumes
marketsDaily volume
2,22,681
Estimated daily volume
2,22,681
Avg. Volume 20 sessions
1,57,299
Daily volume ratio
1.42
Avg. Volume 20 sessions USD
3,932.48
Record volume 1
82,53,86,452
Record volume 2
55,69,30,770
Record volume 3
51,65,46,145
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
66,26,289
Net sales (USD)
59,24,000
Number of employees
272
Sales / Employee (USD)
21,779
Free-Float
14.03 %
Free-Float capitalization (USD)
55,76,103
Average Daily Capital Traded
0.06%
Indicators
Moving average 5 days
0.0258
Moving average 20 days
0.0269
Moving average 50 days
0.0307
Moving average 100 days
0.025
Price spread / (MMA5)
+3.20%
Price spread / (MMA20)
+7.60%
Price spread / (MMA50)
+22.80%
Price spread / (MMA100)
0.00%
STIM
RSI 9 days
47.14
RSI 14 days
46.83
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.85% | 0.00% | -49.19% | -96.60% | 66.26L | |
| -0.33% | -5.21% | +45.12% | -2.77% | 8.06TCr | |
| -1.28% | -3.70% | -19.87% | -37.07% | 5.91TCr | |
| -3.36% | -10.08% | +454.19% | +25.98% | 5.41TCr | |
| +0.83% | -3.26% | -9.28% | +30.44% | 5.01TCr | |
| -1.11% | -7.21% | -2.15% | +147.94% | 4.53TCr | |
| -0.83% | -5.36% | +46.75% | -18.63% | 3.11TCr | |
| +1.29% | -2.19% | +47.21% | +96.95% | 2.55TCr | |
| -3.46% | -7.60% | -4.82% | +147.52% | 2.18TCr | |
| -3.02% | -2.59% | +60.23% | +104.24% | 1.61TCr | |
| Average | -0.99% | -3.41% | +56.82% | +39.80% | 3.84TCr | |
| Weighted average by Cap. | -0.33% | -3.85% | +78.18% | +36.49% |
Historical Quotes: Adaptimmune Therapeutics plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
1e.gVIvbNCX5DFdTxX0dN0mvPELmr4cWnYEz-S5qe6JAlw.-Qt8C6Xu02Rpe2PNJ7dE8Ys9o-Z1Ei5KgdTg673aZAPmG30jmOOzdB4XQA
| Date | Price | Volume | Total |
|---|---|---|---|
| 01:29:25 am | 0.0250 | 1,000 | 2,22,110 |
| 01:18:39 am | 0.0211 | 140 | 2,21,110 |
| 01:12:12 am | 0.0240 | 1,000 | 2,20,970 |
| 12:01:35 am | 0.0211 | 1,100 | 2,19,970 |
| 12:01:35 am | 0.0220 | 400 | 2,18,870 |
| 11:57:16 pm | 0.0250 | 1,500 | 2,18,470 |
| 11:22:01 pm | 0.0211 | 2,222 | 2,16,970 |
| 11:20:55 pm | 0.0250 | 1,000 | 2,14,748 |
| 11:12:53 pm | 0.0210 | 257 | 2,13,748 |
| 11:09:09 pm | 0.0220 | 700 | 2,13,491 |
Price Extremes
| 1 week | 0.02 |  | 0.03 |
| 1 month | 0 | | 0.03 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.28 |
| 3 years | 0 | | 2.05 |
| 5 years | 0 | | 6.84 |
| 10 years | 0 | | 14.62 |
Monthly variations
Annual variations
| 2026 | -3.85% | ||
| 2025 | -95.17% | ||
| 2024 | -32.07% | ||
| 2023 | -45.68% | ||
| 2022 | -61.07% | ||
| 2021 | -30.43% | ||
| 2020 | +349.17% | ||
| 2019 | -79.13% | ||
| 2018 | -13.92% | ||
| 2017 | +64.94% | ||
| 2016 | -66.42% | ||
| 2015 | -30.01% |
- Stock Market
- Stocks
- ADAPY Stock
- Quotes Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
